BALA CYNWYD, Pa., Aug. 6, 2013 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Trius
Therapeutics, Inc. ("Trius" or the "Company") (Nasdaq- TSRX-News)
relating to the proposed acquisition by Cubist Pharmaceuticals,
Inc.
Click here to learn more about the investigation
http://brodsky-smith.com/624-tsrx-trius-therapeutics-inc.html, or
call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Trius shareholders will
receive only $13.50 in cash and a
Contingent Value Right for an additional $2.00 in cash contingent on certain commercial
sales milestones being met for each share of Trius stock they own.
The investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Trius
for not acting in the Company's shareholders' best interests in
connection with the sale process. The transaction may undervalue
the Company as Trius stock traded at $14.10 per share on July
31, 2013 and an analyst has set an $18.00 per share price target on
Trius.
If you own shares of Trius common stock and wish to discuss the
legal ramifications of the proposed transaction, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 602, Bala
Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/624-tsrx-trius-therapeutics-inc.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and case action lawsuits. The attorneys at Brodsky &
Smith have been appointed by numerous courts throughout the country
to serve as lead counsel in class actions and successfully
recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar
outcome.
SOURCE Brodsky & Smith, LLC